Genesis Global
United Kingdom
- London, London
- 16/02/2022
- Series C
- $200,000,000
Genesis enables financial market organizations to innovate at speed through our low-code platform that supercharges developers to build resilient, performant and secure applications with unmatched efficiency and scale.
Genesis provides freedom from legacy and replaces the buy vs. build challenge with a buy-to-build solution.
With years of financial markets and technical expertise, the Genesis team understands how financial markets organizations need to innovate their products, services and applications with speed and agility to maintain a competitive edge. Strategically backed by Citi and trusted by B3, ING and London Clearinghouse, Genesis has global offices in New York (HQ), Miami, London, São Paulo, and Dublin.
- Industry Financial Services
- Website https://new.genesis.global/
- LinkedIn https://www.linkedin.com/company/genesis-global-technology/about/
ZBD | $40,000,000 | (Jan 23, 2026)
Allocation Strategy | $2,164,392 | (Jan 23, 2026)
Asymmetric Security | $4,200,000 | (Jan 23, 2026)
Cubby | $63,000,000 | (Jan 23, 2026)
Cambio | $18,000,000 | (Jan 23, 2026)
Cork Protocol | $5,500,000 | (Jan 23, 2026)
Yuki | $6,000,000 | (Jan 23, 2026)
Mia Labs | $20,000,000 | (Jan 23, 2026)
Mendra | $82,000,000 | (Jan 23, 2026)
Artie Technologies | $12,000,000 | (Jan 23, 2026)
Antidote Legal | $5,000,000 | (Jan 23, 2026)
One to One Health | $12,000,000 | (Jan 22, 2026)